Dr. Toshifumi Hara received a Ph.D. in Medicine in March 2007 and began his academic career as an Assistant Professor at Tokyo Medical and Dental University. From 2011 to 2014, he conducted advanced cancer research as a Visiting Fellow at the National Cancer Institute in the United States, where he contributed to numerous high-impact studies on cancer progression, gene regulation, and microRNA biology. Upon returning to Japan, he served as an Assistant Professor at Niigata University Graduate School before joining the Department of Biochemistry at the School of Pharmacy, Aichi Gakuin University, in January 2017. His research focuses on molecular oncology, with particular interests in epithelial-mesenchymal transition and the role of non-coding RNAs in cancer metastasis. He has co-authored over 30 peer-reviewed publications in leading journals such as Stem Cell Reports, Oncogene, Scientific Reports, and PNAS. Notably, his recent studies have shed light on the mechanisms underlying peritoneal dissemination in scirrhous gastric cancer, emphasizing the clinical significance of targets such as METTL9, CELSR1, and HOTAIR. He continues to explore therapeutic strategies that translate basic molecular insights into clinical applications.